These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 27037853)

  • 21. Early T-Cell Precursor Leukemia: A High-Risk Subtype of Acute Lymphoblastic Leukemia, Single Center Experience in Jordan.
    Halahleh K; Muradi I; Khalil MZ; Halahleh L; Sughayer M; Kamal N; Sultan I; Alrabi K
    Clin Lymphoma Myeloma Leuk; 2023 Nov; 23(11):e411-e419. PubMed ID: 37730482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential impact of asparaginase discontinuation on outcomes of children with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma.
    Ishida H; Imamura T; Kobayashi R; Hashii Y; Deguchi T; Miyamura T; Oda M; Yamamoto M; Okada K; Sano H; Koh K; Yuza Y; Watanabe K; Nishimura N; Takimoto T; Moriya-Saito A; Sekimizu M; Suenobu S; Sunami S; Horibe K
    Cancer Med; 2024 Jun; 13(12):e7246. PubMed ID: 38888368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A seven-color panel including CD34 and TdT could be applied in >97% patients with T cell lymphoblastic leukemia for minimal residual disease detection independent of the initial phenotype.
    Wang YZ; Hao L; Chang Y; Jiang Q; Jiang H; Zhang LP; He LL; Yuan XY; Qin YZ; Huang XJ; Liu YR
    Leuk Res; 2018 Sep; 72():12-19. PubMed ID: 30059823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dismal outcome of relapsed or primary refractory adult T-cell lymphoblastic lymphoma: A retrospective study from China.
    Chen H; Qin Y; Yang J; Liu P; He X; Zhou S; Zhang C; Yang S; Gui L; Sun Y; Shi Y
    Asia Pac J Clin Oncol; 2022 Apr; 18(2):e87-e95. PubMed ID: 34161657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Results and conclusions of the European Intergroup EURO-LB02 trial in children and adolescents with lymphoblastic lymphoma.
    Landmann E; Burkhardt B; Zimmermann M; Meyer U; Woessmann W; Klapper W; Wrobel G; Rosolen A; Pillon M; Escherich G; Attarbaschi A; Beishuizen A; Mellgren K; Wynn R; Ratei R; Plesa A; Schrappe M; Reiter A; Bergeron C; Patte C; Bertrand Y
    Haematologica; 2017 Dec; 102(12):2086-2096. PubMed ID: 28983060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphoblastic lymphoma in childhood and adolescence.
    Schmidt E; Burkhardt B
    Pediatr Hematol Oncol; 2013 Sep; 30(6):484-508. PubMed ID: 23621872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T-cell lymphoblastic lymphoma and T-cell acute lymphoblastic leukemia: a separate entity?
    Hoelzer D; Gökbuget N
    Clin Lymphoma Myeloma; 2009; 9 Suppl 3():S214-21. PubMed ID: 19778844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haploidentical/mismatched hematopoietic stem cell transplantation without in vitro T cell depletion for T cell acute lymphoblastic leukemia.
    Wang Y; Liu DH; Xu LP; Liu KY; Chen H; Chen YH; Han W; Zhang XH; Huang XJ
    Biol Blood Marrow Transplant; 2012 May; 18(5):716-21. PubMed ID: 21924223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adult B- and T-lymphoblastic lymphoma treated with a paediatric acute lymphoblastic leukaemia regimen have excellent outcomes-a short report from two Sydney centres.
    Blennerhassett R; Kwan J; Coyle L; Wong K; Greenwood M
    Br J Haematol; 2020 Oct; 191(2):e58-e60. PubMed ID: 32720705
    [No Abstract]   [Full Text] [Related]  

  • 30. Diagnosis and management of lymphoblastic lymphoma in children, adolescents and young adults.
    Temple WC; Mueller S; Hermiston ML; Burkhardt B
    Best Pract Res Clin Haematol; 2023 Mar; 36(1):101449. PubMed ID: 36907639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ALL-REZ BFM--the consecutive trials for children with relapsed acute lymphoblastic leukemia.
    Henze G; v Stackelberg A; Eckert C
    Klin Padiatr; 2013 May; 225 Suppl 1():S73-8. PubMed ID: 23700062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Results of treatment of lymphoblastic lymphoma at the children cancer hospital Egypt - A single center experience.
    Rahman Sayed HA; Sedky M; Hamoda A; Kinaaie NE; Wakeel ME; Hesham D
    J Egypt Natl Canc Inst; 2016 Sep; 28(3):175-81. PubMed ID: 27339800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nelarabine as salvage therapy and bridge to allogeneic stem cell transplant in 118 adult patients with relapsed/refractory T-cell acute lymphoblastic leukemia/lymphoma. A CAMPUS ALL study.
    Candoni A; Lazzarotto D; Ferrara F; Curti A; Lussana F; Papayannidis C; Del Principe MI; Bonifacio M; Mosna F; Delia M; Minetto P; Gottardi M; Fracchiolla N; Mancini V; Forghieri F; Zappasodi P; Cerrano M; Vitale A; Audisio E; Trappolini S; Romani C; Defina M; Imbergamo S; Ciccone N; Santoro L; Cambò B; Iaccarino S; Dargenio M; Aprile L; Chiaretti S; Fanin R; Pizzolo G; Foà R
    Am J Hematol; 2020 Dec; 95(12):1466-1472. PubMed ID: 32777149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Indication and benefit of upfront hematopoietic stem cell transplantation for T-cell lymphoblastic lymphoma in the era of ALL-type induction therapies.
    Morita-Fujita M; Arai Y; Yoshioka S; Ishikawa T; Kanda J; Kondo T; Akasaka T; Ueda Y; Imada K; Moriguchi T; Yago K; Kitano T; Yonezawa A; Nohgawa M; Takaori-Kondo A;
    Sci Rep; 2020 Dec; 10(1):21418. PubMed ID: 33293600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High efficacy and safety of low-dose CD19-directed CAR-T cell therapy in 51 refractory or relapsed B acute lymphoblastic leukemia patients.
    Pan J; Yang JF; Deng BP; Zhao XJ; Zhang X; Lin YH; Wu YN; Deng ZL; Zhang YL; Liu SH; Wu T; Lu PH; Lu DP; Chang AH; Tong CR
    Leukemia; 2017 Dec; 31(12):2587-2593. PubMed ID: 28490811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B-lineage lymphoblastic lymphoma is a clinicopathologic entity distinct from other histologically similar aggressive lymphomas with blastic morphology.
    Soslow RA; Baergen RN; Warnke RA
    Cancer; 1999 Jun; 85(12):2648-54. PubMed ID: 10375114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of childhood T-cell lymphoblastic lymphoma according to the strategy for acute lymphoblastic leukaemia, without radiotherapy: long term results of the EORTC CLG 58881 trial.
    Uyttebroeck A; Suciu S; Laureys G; Robert A; Pacquement H; Ferster A; Marguerite G; Mazingue F; Renard M; Lutz P; Rialland X; Mechinaud F; Cavé H; Baila L; Bertrand Y;
    Eur J Cancer; 2008 Apr; 44(6):840-6. PubMed ID: 18342502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: a high-risk subtype.
    Jain N; Lamb AV; O'Brien S; Ravandi F; Konopleva M; Jabbour E; Zuo Z; Jorgensen J; Lin P; Pierce S; Thomas D; Rytting M; Borthakur G; Kadia T; Cortes J; Kantarjian HM; Khoury JD
    Blood; 2016 Apr; 127(15):1863-9. PubMed ID: 26747249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical presentation, evolution, and prognosis of precursor B-cell lymphoblastic lymphoma in trials LMT96, EORTC 58881, and EORTC 58951.
    Ducassou S; Ferlay C; Bergeron C; Girard S; Laureys G; Pacquement H; Plantaz D; Lutz P; Vannier JP; Uyttebroeck A; Bertrand Y
    Br J Haematol; 2011 Feb; 152(4):441-51. PubMed ID: 21210776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical outcome of autologous stem cell transplantation as first-line treatment in 30 patients with high risk lymphoblastic lymphoma].
    Huang W; Zou D; Sui W; Wang T; Fu M; Li Z; Xu Y; Zhao Y; Feng S; Han M; Qiu L
    Zhonghua Xue Ye Xue Za Zhi; 2014 Apr; 35(4):332-6. PubMed ID: 24759023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.